Kestra Advisory Services, LLC Horizon Therapeutics Public LTD CO Transaction History

Kestra Advisory Services, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$107.32 - $113.5 $2.88 Million - $3.04 Million	-26,802 Reduced 83.85%	5,161 $563,000
Q4 2022 Jan 31, 2023	SELL	$62.39 - $113.8 $2.16 Million - $3.94 Million	-34,654 Reduced 52.02%	31,963 $3.64 Million
Q3 2022 Nov 01, 2022	BUY	$58.92 - $84.67 $1.58 Million - $2.26 Million	26,739 Added 67.05%	66,617 $4.12 Billion
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $575,808 - $843,842	7,252 Added 22.23%	39,878 $3.18 Million
Q1 2022 Apr 26, 2022	BUY	$86.42 - $109.81 $225,901 - $287,043	2,614 Added 8.71%	32,626 $3.43 Million
Q4 2021 Jan 20, 2022	BUY	$98.56 - $119.91 $650,003 - $790,806	6,595 Added 28.16%	30,012 $3.23 Million
Q3 2021 Oct 19, 2021	BUY	$91.91 - $110.37 $279,590 - $335,745	3,042 Added 14.93%	23,417 $2.57 Million
Q2 2021 Jul 28, 2021	BUY	$86.24 - $95.92 $337,974 - $375,910	3,919 Added 23.82%	20,375 $1.91 Million
Q1 2021 May 10, 2021	SELL	$71.83 - $95.48 $1.89 Million - $2.51 Million	-26,306 Reduced 61.52%	16,456 $1.51 Million
Q4 2020 Jan 20, 2021	BUY	$67.0 - $84.39 $2.09 Million - $2.64 Million	31,235 Added 270.97%	42,762 $3.09 Billion
Q3 2020 Nov 12, 2020	BUY	$55.23 - $79.93 $636,636 - $921,353	11,527 New	11,527 $895 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.